| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Albany Molecular | 598,200 | 9,739,000 | 17.80% | ||
| 2 | ASTRAZENECA PLC | 100,000 | 7,038,000 | 12.86% | ||
| 3 | TEVA PHARMACEUTICAL INDS LTD | 100,000 | 5,751,000 | 10.51% | ||
| 4 | QUEST DIAGNOSTICS INC | 77,208 | 5,178,000 | 9.46% | ||
| 5 | PFIZER INC | 150,000 | 4,673,000 | 8.54% | ||
| 6 | PROSHARES ULTRASHORT RUSSELL2000 | 100,000 | 3,959,000 | 7.24% | ||
| 7 | LIGAND PHARMACEUTICALS INC | 50,000 | 2,661,000 | 4.86% | ||
| 8 | CRYOLIFE INC | 200,000 | 2,266,000 | 4.14% | ||
| 9 | Albany Molecular | 120,000 | 1,954,000 | 3.57% | Call | |
| 10 | SORRENTO THERAPEUTICS INC COM NEW | 180,479 | 1,817,000 | 3.32% | ||
| 11 | QLT INC | 350,000 | 1,404,000 | 2.57% | ||
| 12 | ARIAD PHARMACEUTICALS INC | 150,000 | 1,031,000 | 1.88% | ||
| 13 | CEMPRA INC | 40,000 | 940,000 | 1.72% | Call | |
| 14 | RIGEL PHARMACEUTICAL INC | 400,000 | 908,000 | 1.66% | ||
| 15 | CYTOKINETICS INC | 100,000 | 801,000 | 1.46% | ||
| 16 | ARIAD PHARMACEUTICALS INC | 100,000 | 687,000 | 1.26% | Call | |
| 17 | QLT INC | 150,000 | 602,000 | 1.10% | Call | |
| 18 | ALIMERA SCIENCES INC | 100,000 | 554,000 | 1.01% | ||
| 19 | Sunesis Pharmaceuticals I | 200,000 | 510,000 | 0.93% | ||
| 20 | AMARIN CORP PLC | 500,000 | 490,000 | 0.90% | Call | |
| 21 | FIBROCELL SCIENCE INC | 157,769 | 409,000 | 0.75% | ||
| 22 | POZEN INC | 50,000 | 400,000 | 0.73% | Call | |
| 23 | STEMLINE THERAPEUTICS INC | 16,464 | 281,000 | 0.51% | ||
| 24 | ALIMERA SCIENCES INC | 50,000 | 277,000 | 0.51% | Call | |
| 25 | CELSION CORPORATION COM PAR $0.01 | 100,000 | 233,000 | 0.43% | ||
| 26 | CATALYST PHARMACEUTICALS INC | 50,000 | 149,000 | 0.27% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-15-001370, filed 2015.02.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
